Premium
Chlamydia screening — Australia should strive to achieve what others have not
Author(s) -
Hocking Jane S,
Walker Jennifer,
Regan David,
Chen Marcus Y,
Fairley Christopher K
Publication year - 2008
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.2008.tb01533.x
Subject(s) - chlamydia , government (linguistics) , public health , chlamydia trachomatis , medicine , family medicine , business , environmental health , political science , gynecology , immunology , nursing , linguistics , philosophy
Chlamydia screening programs overseas have failed to reduce chlamydia prevalence despite screening 20%–30% of young sexually active women. The Australian federal government announced in 2005 that it would provide $12.5 million for chlamydia control. Policymakers must look to chlamydia screening programs in other countries to learn from their experience. Australia has an excellent primary health care system and a strong track record in establishing highly successful public health programs. This experience places it in a strong position to design and implement an innovative chlamydia screening program to reduce chlamydia prevalence.